CoinW Unveils Spot Trading Upgrade on Its 8th Anniversary
HONG KONG, Sept. 22, 2025 /PRNewswire/ -- Spot trading is the foundation…
CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders
New York, Sept. 21, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq:…
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind.,…
Spencer’s Tunick art installation “Retrato Alhambra1925” highlights Cervezas Alhambra’s 100th anniversary of its Andalusian roots
The art event, held in an olive grove in Granada, brought together…
CGTNXinjiang in its most prosperous period ever: white paper
BEIJING, Sept. 20, 2025 /PRNewswire/ -- Today's Xinjiang is experiencing the best period…
Herbalife India Launches New Episode of Its Flagship Podcast Featuring Dr. Shivangi Rana
'Live Your Best Life, Unscripted': A Deep Dive into Skincare, Science &…
LAKM UNVEILS ITS BE-JEWEL COLLECTION WITH BRAND AMBASSADORS KAREENA KAPOOR KHAN AND ANEET PADDA: MODERNIZING MAXIMALISM AS EVERYDAY SOFT GLAM
From Kareena's timeless glamour to Aneet's playful spirit, Lakmē Be-Jewel redefines maximalism…
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
GIGABYTE Announces the Availability of its AI-enhanced AORUS X870E X3D Series Motherboards for AMD Ryzen X3D Processors
TAIPEI, Sept. 17, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
